The Midlife Transition RX Hormone Replacement Therapy and Specialty Considerations for Providers and Clinicians in Women’s Health and Female Readiness January 29, 2026

https://www.dhaj7-cepo.com/content/midlife-transition?utm_source=newsletter&utm_medium=email&utm_campaign=december2025 The Midlife Transition RX Hormone Replacement Therapy and Specialty Considerations for Providers and Clinicians in Women’s Health and Female Readiness Thursday, January 29, 2026, at 9:30 a.m. ET This all-day, virtual event unpacks the science of perimenopause and menopause through a range of topics, including insights from the Women’s Health Initiative long-term study, the FDA decision to remove black box warnings on estrogen products for hormone replacement therapy, and hormone replacement therapy’s safety, benefits, and prescribing tools.